Trial Profile
Pharmacokinetic Properties of TAC-202 in the Fed and Fasted Conditions
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Jun 2016
Price :
$35
*
At a glance
- Drugs Bilastine (Primary)
- Indications Allergic conjunctivitis; Allergic rhinoconjunctivitis; Perennial allergic rhinitis; Seasonal allergic rhinitis; Urticaria
- Focus Pharmacokinetics
- Sponsors Taiho Pharmaceutical
- 07 Jun 2016 New trial record